Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (Q76340017)
Jump to navigation
Jump to search
scientific article published on 16 February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin |
scientific article published on 16 February 2004 |
Statements
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial (English)
Christoph Stellbrink
Uwe Nixdorff
Thomas Hofmann
Walter Lehmacher
Werner Günther Daniel
Peter Hanrath
Christoph Geller
Andreas Mügge
Walter Sehnert
Caroline Schmidt-Lucke
Jan-André Schmidt-Lucke
ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group
16 February 2004